Pages that link to "Q38119883"

The following pages link to Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review (Q38119883):

Displaying 36 items.

• Allergic respiratory disease (ARD), setting forth the basics: proposals of an expert consensus report (Q33706588) (← links)
• Immunotherapy for house dust mite sensitivity: where are the knowledge gaps? (Q34445398) (← links)
• Clinical practice guideline: Allergic rhinitis (Q34460983) (← links)
• The safety of self-administered allergen immunotherapy during the buildup and maintenance phases (Q35733569) (← links)
• Sublingual Immunotherapy for Asthmatic Children Sensitized to House Dust Mite: A Meta-Analysis (Q36194445) (← links)
• Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapy (Q36619339) (← links)
• The efficacy assessment of a self-administered immunotherapy protocol (Q36881918) (← links)
• Allergic rhinitis: the "Ghost Diagnosis" in patients with asthma (Q37481236) (← links)
• Emerging drugs for allergic conjunctivitis (Q38198760) (← links)
• Subcutaneous immunotherapy (Q38245584) (← links)
• Five-grass-pollen sublingual immunotherapy tablet for the treatment of grass-pollen-induced allergic rhinoconjunctivitis: 5 years of experience (Q38247821) (← links)
• Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety (Q38284820) (← links)
• Developing therapies for peanut allergy (Q38296706) (← links)
• The relationship between allergen immunotherapy and omalizumab for treating asthma. (Q38314276) (← links)
• Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review (Q38366788) (← links)
• Advances in pharmacotherapy for allergic conjunctivitis (Q38460976) (← links)
• Current developments for improving efficacy of allergy vaccines. (Q38503330) (← links)
• Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews. (Q38631412) (← links)
• Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews (Q38641971) (← links)
• The future of immunotherapy for canine atopic dermatitis: a review. (Q38764527) (← links)
• Immunotherapy in allergic rhinitis and lower airway outcomes. (Q38903486) (← links)
• Regulation of Trek1 expression in nasal mucosa with allergic rhinitis by specific immunotherapy (Q38926592) (← links)
• For t 2 DNA vaccine prevents Forcipomyia taiwana (biting midge) allergy in a mouse model (Q38926808) (← links)
• Allergen immunotherapy in asthma; what is new? (Q39038000) (← links)
• The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment (Q39380921) (← links)
• The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow's milk- and peanut allergy models. (Q42079184) (← links)
• Allergen-Specific Immunotherapy in Asthma (Q42587580) (← links)
• Immunotherapy of house dust mite allergy (Q43915564) (← links)
• Efficacy and Safety of Subcutaneous Allergen Immunotherapy for Allergic Rhinitis (Q47118742) (← links)
• Chinese Guideline on allergen immunotherapy for allergic rhinitis (Q47149942) (← links)
• Immunotherapy for pet allergies (Q47697735) (← links)
• House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial (Q47940422) (← links)
• International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (Q49025332) (← links)
• Antigen-specific regulatory T-cell responses against aeroantigens and their role in allergy (Q56956806) (← links)
• Reliability of the Evidence Addressing Treatment of Corneal Diseases: A Summary of Systematic Reviews (Q91879800) (← links)
• A contemporary look at allergic conjunctivitis (Q93014266) (← links)